Literature DB >> 28384518

Semiology of subtle motor phenomena in critically ill patients.

Bogdan Florea1, Simona Alexandra Beniczky2, Helga Demény3, Sándor Beniczky4.   

Abstract

PURPOSE: to investigate the semiology of subtle motor phenomena in critically ill patients, with- versus without nonconvulsive status epilepticus (NCSE).
METHODS: 60 consecutive comatose patients, in whom subtle motor phenomena were observed in the intensive care unit (ICU), were analysed prospectively. The semiology of the subtle phenomena was described from video-recordings, blinded to all other data. For each patient, the type, location and occurrence-pattern/duration were described. EEGs recorded in the ICU were classified using the Salzburg criteria for NCSE.
RESULTS: only 23% (14/60) of the patients had NCSE confirmed by EEG. None of the semiological features could distinguish between patients with NCSE and those without. In both groups, the following phenomena were most common: discrete myoclonic muscle twitching and discrete tonic muscle activation. Besides these, automatisms and eye deviation were observed in both groups.
CONCLUSION: subtle motor phenomena in critically ill patients can raise the suspicion of NCSE. Nevertheless, EEG is needed to confirm the diagnosis, since none of the semiological features are specific.
Copyright © 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coma; EEG; Nonconvulsive status epilepticus; Semiology

Mesh:

Year:  2017        PMID: 28384518     DOI: 10.1016/j.seizure.2017.03.018

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  2 in total

1.  Defining a Place for Lacosamide in the Intensive Care Unit.

Authors:  R Edward Faught
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

2.  Quantitative Infrared Pupillometry in Nonconvulsive Status Epilepticus.

Authors:  Jana Godau; Claudia Bierwirth; Johannes Rösche; Julian Bösel
Journal:  Neurocrit Care       Date:  2020-11-20       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.